ACC Rockies Chapter Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.


For more information and to register, please visit: ACC Rockies Chapter Meeting 2026



ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • DECIPHER HFpEF: CMR Tissue Mapping Tracks HFpEF Mechanisms Beyond Filling Pressure
    Cardiac magnetic resonance (CMR) tissue mapping captured active relaxation impairment (σ) and passive stiffness (β) in invasively characterized heart failure with preserved ejection fraction (HFpEF), even after accounting for end-diastolic pressure (EDP) and covariates including age, sex, BMI, hypertension and diabetes...
  • ACC Scientific Statement Says Overall Diet Quality Key to Maintaining Heart Health
    A healthy, balanced dietary pattern, rather than one focused on individual nutrients or foods, is key to maintaining heart health, according to a new ACC Scientific Statement on Food and Health: Nutrition for Prevention and Management of Cardiovascular Disease.
  • Eagle’s Eye View: How Does Whole Grain Intake Impact CV Health?
    In this week’s View, Dr. Eagle looks at how higher whole-grain intake was associated with improvements in multiple cardiometabolic risk factors in a meta-analysis of randomized trials.
  • Atenolol Associated With Lower MACE Risk After MI Than Bisoprolol
    Among patients without recorded heart failure (HF), starting atenolol after a myocardial infarction (MI) was associated with a lower two-year risk of major adverse cardiovascular events (MACE), but not all-cause mortality, compared with bisoprolol, according to an observational cohort study published Sept. 22 in NEJM Evidence.
  • ACC/AHA Joint Guideline Committee Reaffirms Perioperative Guideline
    After evaluating new evidence published over the last two years on perioperative cardiovascular management of patients following noncardiac surgery, the ACC/AHA Joint Committee on Clinical Practice Guidelines has determined that the most recent perioperative guideline published in 2024 “remains valid and current.” Read the full guideline published in JACC.